Foundation Fighting Blindness Announces Completion of Phase One of the #HowEyeSeeIt Campaign

October 06, 2016

The #HowEyeSeeIt campaign is a national public education initiative designed to both raise awareness of retinal degenerative diseases and to raise funds to support research on treatments for these inherited, vision-robbing conditions.

The campaign is rooted in how people see the world and its possibilities, with or without sight. The five official campaign videos focus on this message and share stories of blind people teaching sighted people how to do what they love in a different way.

The blindfold challenge component of the campaign continued this theme of experiencing the world through another person’s eyes.  We thank the thousands of people who participated in the challenge by trying an everyday task while blindfolded.

During the first phase of the campaign, nearly 58 million people saw campaign messages and over $100,000 was raised to support retinal disease research. The end of phase one of the #HowEyeSeeIt campaign completes the blindfold challenge. Phase two of the campaign will feature profiles of people with no or low vision, showcasing their adaptability, strength and talent.

Until there’s a cure, the Foundation Fighting Blindness will continue to raise the funds needed to drive the research that is progressing toward a cure and will celebrate the skills, talents and resilience of all members of the retinal degenerative disease community.

We acknowledge and are sensitive to the concerns expressed by the National Federation of the Blind that the challenge activity may have reinforced unfounded and negative stereotypes about blind people. The purpose of the blindfold experience was to increase participants’ appreciation for two things: the gift of sight and the skills and strengths of their family members, co-workers, friends and neighbors who live their lives productively with low or no vision. Most people who participated in the challenge reported gaining new insight into the strengths and adaptability of people who have lost their sight.

FFB is proud of its 45 year tenure as the world’s leading private funder of retinal disease research with more than $700 million invested in its mission to advance the research aimed at preventing, treating and curing blindness caused by retinal degenerative diseases. In excess of 10 million Americans, and many times that number worldwide, have vision loss due to retinal degeneration. Each funded study brings the science closer to a cure. Today, more than 20 clinical trials are underway using gene, stem cell, medical and nutritional therapies with many more in the pipeline. Most of these human studies were made possible by Foundation research investments.

To learn more about the campaign or to make a donation to support retinal disease research visit the campaign website at